Cargando…
Feasibility of ApoC1 serum levels as tumor biomarker in glioblastoma patients: a pilot study
Apolipoprotein C1 (ApoC1) has been detected immunohistochemically in glioblastoma tissue, probably expressed by activated monocytes and microglia. The present study was conceived to determine whether the amount of intratumoral ApoC1 expression leads to measurable changes of serum levels after gliobl...
Autores principales: | Hilbert, Michelle, Kuzman, Peter, Mueller, Wolf C., Meixensberger, Jürgen, Nestler, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550816/ https://www.ncbi.nlm.nih.gov/pubmed/36216850 http://dx.doi.org/10.1038/s41598-022-21216-1 |
Ejemplares similares
-
The Mean ApoC1 Serum Level in Postoperative Samples from Neurosurgical Patients Is Lower than in Preoperative Samples and during Chemotherapy
por: Hilbert, Michelle, et al.
Publicado: (2022) -
Assessment of ApoC1, LuzP6, C12orf75 and OCC-1 in cystic glioblastoma using MALDI–TOF mass spectrometry, immunohistochemistry and qRT-PCR
por: Evangelou, Petros, et al.
Publicado: (2019) -
AAV-Mediated ApoC2 Gene Therapy: Reversal of Severe Hypertriglyceridemia and Rescue of Neonatal Death in ApoC2-Deficient Hamsters
por: Yang, Chun, et al.
Publicado: (2020) -
Increased L1CAM (CD171) levels are associated with glioblastoma and metastatic brain tumors
por: Wachowiak, Robin, et al.
Publicado: (2018) -
Familial glioblastoma clustering in adult patients: a case report of two non-twin siblings and review of the literature
por: Sander, Caroline, et al.
Publicado: (2019)